Local Immunological Effect of Neoadjuvant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Cancer

被引：0
|
作者：
Murakami, T. [1 ]
Mori, R. [1 ]
Matsuyama, R. [1 ]
Homma, Y. [1 ]
Nakazawa, M. [2 ]
Tanaka, Y. [1 ]
Miyake, K. [1 ]
Sawada, Y. [1 ]
Oota, Y. [1 ]
Hiroshima, Y. [1 ]
Kumamoto, T. [1 ]
Ueda, M. [1 ]
Takeda, K. [1 ]
Ichikawa, Y. [1 ]
Tanaka, K. [1 ]
Endo, I. [1 ]
机构：
[1] Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Yokohama, Kanagawa 232, Japan
[2] Yokohama City Univ, Grad Sch Med, Dept Expt Anim Med, Yokohama, Kanagawa 232, Japan
来源：
PANCREAS | 2014年 / 43卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1394 / 1394
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer
    Lee, Sang Hoon
    [J]. KOREAN JOURNAL OF GASTROENTEROLOGY, 2024, 84 (03): : 103 - 110
  • [22] Significance of neoadjuvant chemoradiotherapy for borderline resectable pancreatic head cancer: Pathological local invasion and microvessel invasion analysis
    Naito, Yoshiki
    Ishikawa, Hiroto
    Sadashima, Eiji
    Okabe, Yoshinobu
    Takahashi, Kenjiro
    Kawahara, Ryuichi
    Hisaka, Toru
    Fukahori, Masaru
    Ushijima, Tomoyuki
    Ishida, Yusuke
    Tanigawa, Masahiko
    Mihara, Yutaro
    Nakayama, Masamichi
    Kondo, Reiichiro
    Kusano, Hironori
    Takase, Yorihiko
    Abe, Hideyuki
    Ogo, Etsuyo
    Okuda, Koji
    Shimamatsu, Kazuhide
    Yano, Hirohisa
    Akiba, Jun
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2019, 11 (03) : 225 - 233
  • [23] Neoadjuvant Chemoradiotherapy With S-1 in Patients With Borderline Resectable Pancreatic Cancer with Involvement of the Major Artery
    Suenaga, M.
    Fujii, T.
    Yamada, S.
    Okumura, N.
    Kobayashi, D.
    Tanaka, C.
    Nakayama, G.
    Sugimoto, H.
    Koike, M.
    Nomoto, S.
    Fujiwara, M.
    Takeda, S.
    Nakao, A.
    Kodera, Y.
    [J]. PANCREAS, 2012, 41 (08) : 1405 - 1405
  • [24] The role of neoadjuvant chemoradiotherapy in resectable pancreatic cancer
    Kim, H. J.
    Bang, S.
    Park, S. W.
    Chung, J. B.
    Song, S. Y.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A138 - A138
  • [25] MZB1 in borderline resectable pancreatic cancer resected after neoadjuvant chemoradiotherapy
    Miyake, Kentaro
    Mori, Ryutaro
    Homma, Yuki
    Matsuyama, Ryusei
    Okayama, Akiko
    Murakami, Takashi
    Hirano, Hisashi
    Endo, Itaru
    [J]. JOURNAL OF SURGICAL RESEARCH, 2017, 220 : 391 - 401
  • [26] Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer
    Barreto, Savio George
    Shrikhande, Shailesh, V
    Sirohi, Bhawna
    [J]. INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2024, 15 (SUPPL 2) : 249 - 254
  • [27] Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer
    Kharofa, Jordan
    Tsai, Susan
    Kelly, Tracy
    Wood, Clint
    George, Ben
    Ritch, Paul
    Wiebe, Lauren
    Christians, Kathleen
    Evans, Douglas B.
    Erickson, Beth
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 113 (01) : 41 - 46
  • [28] Strategy of Neoadjuvant Therapy for Resectable/Borderline Resectable Pancreatic Cancer
    Hashimoto, D.
    Satoi, S.
    Yamamoto, T.
    Yamaki, S.
    Hirooka, S.
    Ishida, M.
    Ikeura, T.
    Sekimoto, M.
    [J]. PANCREAS, 2021, 50 (07) : 1064 - 1064
  • [29] Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
    Massani, Marco
    Stecca, Tommaso
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [30] Neoadjuvant treatment of primarily resectable and borderline resectable pancreatic cancer
    Scheufele, F.
    Friess, H.
    [J]. CHIRURG, 2020, 91 (05): : 391 - 395
12345